Q2 EPS Forecast for Core Laboratories Lowered by Analyst

Core Laboratories Inc. (NYSE:CLB) – Research analysts at Zacks Research decreased their Q2 2025 EPS estimates for shares of Core Laboratories in a research report issued on Wednesday, March 26th. Zacks Research analyst T. Saha now expects that the oil and gas company will post earnings per share of $0.21 for the quarter, down from their previous estimate of $0.25. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q1 2026 earnings at $0.18 EPS, Q4 2026 earnings at $0.34 EPS and FY2027 earnings at $1.28 EPS.

Separately, Citigroup upgraded shares of Core Laboratories from a “sell” rating to a “neutral” rating and increased their target price for the company from $15.00 to $16.00 in a report on Wednesday, March 12th. One analyst has rated the stock with a sell rating and four have given a hold rating to the company’s stock. According to data from MarketBeat, Core Laboratories presently has a consensus rating of “Hold” and a consensus target price of $17.50.

Core Laboratories Price Performance

Shares of NYSE:CLB opened at $15.30 on Friday. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49. The stock has a market cap of $716.45 million, a PE ratio of 23.18, a price-to-earnings-growth ratio of 0.99 and a beta of 2.38. The stock’s fifty day simple moving average is $16.44 and its two-hundred day simple moving average is $18.10. Core Laboratories has a 1-year low of $12.95 and a 1-year high of $25.13.

Core Laboratories (NYSE:CLB) last posted its earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%.

Institutional Investors Weigh In On Core Laboratories

A number of hedge funds have recently made changes to their positions in CLB. Assetmark Inc. purchased a new stake in Core Laboratories during the fourth quarter worth about $26,000. Smartleaf Asset Management LLC boosted its stake in Core Laboratories by 173.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company’s stock valued at $35,000 after acquiring an additional 1,293 shares during the last quarter. Nisa Investment Advisors LLC grew its position in shares of Core Laboratories by 2,688.5% during the 4th quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company’s stock valued at $42,000 after acquiring an additional 2,339 shares during the period. Tower Research Capital LLC TRC increased its stake in shares of Core Laboratories by 843.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company’s stock worth $57,000 after purchasing an additional 2,936 shares during the last quarter. Finally, BNP Paribas Financial Markets bought a new stake in shares of Core Laboratories in the 4th quarter worth approximately $123,000. 97.81% of the stock is currently owned by institutional investors.

Core Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Monday, February 10th were paid a $0.01 dividend. The ex-dividend date was Monday, February 10th. This represents a $0.04 dividend on an annualized basis and a yield of 0.26%. Core Laboratories’s dividend payout ratio (DPR) is presently 6.06%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.